Pfizer vaccine has 100 percent efficacy in young people, trial shows
Stay updated with the latest in Tech, Science, Culture, Entertainment, and more by following our Telegram channel here.
Many people across the world have already received their doses of the Pfizer-BioNTech COVID-19 vaccine, and so far, post-inoculation observations have been showing encouraging signs of efficacy in adults.
To add to that success, a recent Phase III clinical trial has shown that the vaccine displays even higher efficacy in young people, aged 12 to 15 years old, when…
Post comments (0)